AngioDynamics, Inc. (ANGO) Debt Components
- 2024-05-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term Line of CreditUSD (m); Long-term DebtUSD $0.00.
- 2023-05-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term Line of CreditUSD (m); Long-term DebtUSD $49.82M.
- 2023-05-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term Line of CreditUSD (m); Long-term DebtUSD (m).
- 2023-02-28: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term Line of CreditUSD (m); Long-term DebtUSD $49.81M.
AngioDynamics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Line of Credit USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Line of Credit Facility, Current Borrowing Capacity USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount (Premium), Net USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD | Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum (Deprecated 2016-01-31) pure |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-31 | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-05-31 | (m) | (m) | (m) | $49.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-05-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $182.00K | (m) |
| 2023-02-28 | (m) | (m) | (m) | $49.81M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-11-30 | (m) | (m) | (m) | $49.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-08-31 | (m) | (m) | (m) | $49.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-05-31 | (m) | (m) | (m) | $25.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-05-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-02-29 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-11-30 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-08-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-05-31 | $7.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-05-31 | (m) | $124.41M | (m) | $131.91M | (m) | (m) | (m) | (m) | (m) | $132.50M | $593.00K | (m) | (m) |
| 2019-02-28 | $6.25M | $126.84M | (m) | $133.09M | (m) | (m) | (m) | (m) | (m) | $133.75M | $663.00K | (m) | (m) |
| 2018-11-30 | $5.00M | $139.27M | (m) | $144.27M | (m) | (m) | (m) | (m) | (m) | $145.00M | $734.00K | (m) | (m) |
| 2018-08-31 | $5.00M | $85.44M | (m) | $90.44M | (m) | (m) | (m) | (m) | (m) | $91.25M | $806.00K | (m) | (m) |
| 2018-05-31 | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-05-31 | (m) | $86.62M | (m) | $91.62M | (m) | (m) | (m) | (m) | (m) | $92.50M | $879.00K | (m) | (m) |
| 2018-02-28 | $5.00M | $87.80M | (m) | $92.80M | (m) | (m) | (m) | (m) | (m) | $93.75M | $952.00K | (m) | (m) |
| 2017-11-30 | $5.00M | $88.97M | (m) | $93.97M | (m) | (m) | (m) | (m) | (m) | $95.00M | $1.03M | (m) | (m) |
| 2017-08-31 | $5.00M | $90.15M | (m) | $95.15M | (m) | (m) | (m) | (m) | (m) | $96.25M | $1.10M | (m) | (m) |
| 2017-05-31 | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-05-31 | (m) | $91.32M | (m) | $96.32M | (m) | (m) | (m) | (m) | (m) | $97.50M | $1.18M | (m) | (m) |
| 2017-02-28 | $5.00M | $92.52M | (m) | $97.52M | (m) | (m) | (m) | (m) | (m) | $98.75M | $1.23M | (m) | (m) |
| 2016-11-30 | $5.00M | $110.16M | (m) | $115.16M | (m) | (m) | (m) | (m) | (m) | $116.47M | $1.31M | (m) | (m) |
| 2016-08-31 | $17.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-05-31 | $16.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-02-29 | $12.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-11-30 | $11.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-08-31 | $10.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-05-31 | $8.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-02-28 | $7.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-11-30 | $6.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-08-31 | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-05-31 | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-05-31 | (m) | $137.66M | $46.41M | $142.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-02-28 | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-11-30 | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-19 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $100.00M | (m) | (m) | (m) | (m) |
| 2013-08-31 | $13.12M | $129.38M | (m) | (m) | (m) | (m) | (m) | (m) | $50.00M | (m) | (m) | (m) | (m) |
| 2013-05-31 | $7.50M | $135.00M | $0.00 | $142.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-05-31 | (m) | (m) | (m) | (m) | $7.50M | $22.50M | $37.50M | $75.00M | $50.00M | (m) | (m) | (m) | (m) |
| 2013-02-28 | $7.50M | $136.88M | (m) | (m) | (m) | (m) | (m) | (m) | $50.00M | (m) | (m) | (m) | (m) |
| 2012-11-30 | $7.50M | $138.75M | (m) | (m) | (m) | (m) | (m) | (m) | $50.00M | (m) | (m) | (m) | (m) |
| 2012-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 1.00% |
| 2012-08-31 | $7.50M | $140.62M | (m) | (m) | (m) | (m) | (m) | (m) | $50.00M | (m) | (m) | (m) | (m) |
| 2012-05-31 | $7.50M | $142.50M | (m) | $150.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-02-29 | $295.00K | $6.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-11-30 | $290.00K | $6.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-08-31 | $285.00K | $6.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-05-31 | $275.00K | $6.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |